Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Douglas Biggar

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pediatrics in Review|March 3, 2006
Duchenne muscular dystrophyW Douglas Biggar
Journal of Neuromuscular Diseases|June 20, 2022
Comparing Deflazacort and Prednisone in Duchenne Muscular DystrophyW Douglas Biggar, Andrew Skalsky, Craig M McDonald
The Journal of Bone and Joint Surgery. American Volume|March 5, 2004
Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophyBenjamin A Alman, S Naweed Raza, W Douglas Biggar
Neuromuscular Disorders : NMD|August 28, 2012
Fat Embolism Syndrome following minor trauma in Duchenne muscular dystrophyLaura C McAdam, Anjali Rastogi, Kathleen Macleod, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|June 5, 2012
The Canadian experience with long-term deflazacort treatment in Duchenne muscular dystrophyLaura C McAdam, Amanda L Mayo, Benjamin A Alman, et al.
The Journal of Bone and Joint Surgery. American Volume|June 21, 2013
Glucocorticoid treatment for the prevention of scoliosis in children with Duchenne muscular dystrophy: long-term follow-upDavid E Lebel, John A Corston, Laura C McAdam, et al.
Clinical Orthopaedics and Related Research|August 2, 2002
Duchenne muscular dystrophy: current knowledge, treatment, and future prospectsW Douglas Biggar, Henry J Klamut, Paula C Demacio, et al.
Archives of Physical Medicine and Rehabilitation|February 12, 2005
Alendronate in the treatment of low bone mass in steroid-treated boys with Duchennes muscular dystrophyGillian A Hawker, Rowena Ridout, Vivien A Harris, et al.
Journal of Neuromuscular Diseases|August 12, 2017
Development of a New Self-Reporting Instrument Measuring Benefits and Side Effects of Corticosteroids in Duchenne Muscular Dystrophy: Report from a Pilot StudyRuben G F Hendriksen, Judith M Lionarons, Jos G M Hendriksen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pediatrics in Review|March 3, 2006
Duchenne muscular dystrophyW Douglas Biggar
Journal of Neuromuscular Diseases|June 20, 2022
Comparing Deflazacort and Prednisone in Duchenne Muscular DystrophyW Douglas Biggar, Andrew Skalsky, Craig M McDonald
The Journal of Bone and Joint Surgery. American Volume|March 5, 2004
Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophyBenjamin A Alman, S Naweed Raza, W Douglas Biggar
Neuromuscular Disorders : NMD|August 28, 2012
Fat Embolism Syndrome following minor trauma in Duchenne muscular dystrophyLaura C McAdam, Anjali Rastogi, Kathleen Macleod, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|June 5, 2012
The Canadian experience with long-term deflazacort treatment in Duchenne muscular dystrophyLaura C McAdam, Amanda L Mayo, Benjamin A Alman, et al.
The Journal of Bone and Joint Surgery. American Volume|June 21, 2013
Glucocorticoid treatment for the prevention of scoliosis in children with Duchenne muscular dystrophy: long-term follow-upDavid E Lebel, John A Corston, Laura C McAdam, et al.
Clinical Orthopaedics and Related Research|August 2, 2002
Duchenne muscular dystrophy: current knowledge, treatment, and future prospectsW Douglas Biggar, Henry J Klamut, Paula C Demacio, et al.
Archives of Physical Medicine and Rehabilitation|February 12, 2005
Alendronate in the treatment of low bone mass in steroid-treated boys with Duchennes muscular dystrophyGillian A Hawker, Rowena Ridout, Vivien A Harris, et al.
Journal of Neuromuscular Diseases|August 12, 2017
Development of a New Self-Reporting Instrument Measuring Benefits and Side Effects of Corticosteroids in Duchenne Muscular Dystrophy: Report from a Pilot StudyRuben G F Hendriksen, Judith M Lionarons, Jos G M Hendriksen, et al.
Pageof 1